These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2650231)
1. Non-complement-fixing antibodies as indicators for impending renal allograft rejection. Daniel V; Berteli AJ; Röhl L; Pomer S; Opelz G Transplant Proc; 1989 Feb; 21(1 Pt 1):702-3. PubMed ID: 2650231 [No Abstract] [Full Text] [Related]
2. Retrospective analysis of T and B cells flow-cross matches in renal transplant recipients. C LK; Kamaraju SR; Kancherla R Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):571-3. PubMed ID: 18580015 [TBL] [Abstract][Full Text] [Related]
4. [Monitoring and treatment strategy for chronic renal allograft rejection]. Kyo M; Namba Y; Takahara S Nihon Jinzo Gakkai Shi; 2008; 50(7):894-8. PubMed ID: 19069146 [No Abstract] [Full Text] [Related]
5. Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection. von Willebrand E; Häyry P Transplant Proc; 1987 Feb; 19(1 Pt 2):1644-5. PubMed ID: 3079030 [No Abstract] [Full Text] [Related]
6. Diagnosis of human allograft rejection by flow cytometry using two-color fluorescence and monoclonal antibodies. Cunningham P; Gross U; Matthews C; Thomas J; Silverman J; Thomas F Transplant Proc; 1987 Feb; 19(1 Pt 2):1578-9. PubMed ID: 3274388 [No Abstract] [Full Text] [Related]
7. Influence of pretransplant antibodies on early renal allograft rejection. Alarif L; Rodriguez R; Blackburn S; Light JA Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869 [No Abstract] [Full Text] [Related]
8. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764 [TBL] [Abstract][Full Text] [Related]
9. The effect of major histocompatibility complex matching on renal pathology and OKT4/OKT8 (CD4/CD8) ratio in renal allograft rejection. Smart YC; Nanra RS; Hibberd AD; Burton RC Transplant Proc; 1987 Feb; 19(1 Pt 2):1627-8. PubMed ID: 3152632 [No Abstract] [Full Text] [Related]
10. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Thistlethwaite JR; Buckingham M; Stuart JK; Gaber AO; Mayes JT; Stuart FP Transplant Proc; 1987 Feb; 19(1 Pt 1):722-4. PubMed ID: 3079164 [No Abstract] [Full Text] [Related]
11. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft]. Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734 [No Abstract] [Full Text] [Related]
12. Monoclonal antibody identification of nucleated cells in urine: diagnosis of allograft rejection. Segasothy M; Birch DF; Fairley KF; Kincaid-Smith P Transplant Proc; 1989 Feb; 21(1 Pt 2):1878-9. PubMed ID: 2652610 [No Abstract] [Full Text] [Related]
18. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675 [TBL] [Abstract][Full Text] [Related]
19. Role of T-cell-subset monitoring in renal-allograft recipients. Morris PJ; Carter NP; Cullen PR; Thompson JF; Wood RF N Engl J Med; 1982 May; 306(18):1110-1. PubMed ID: 7040954 [No Abstract] [Full Text] [Related]
20. Renal transplantation efficacy is dependent on pretransplantation immunologic monitoring. Drannik GN; Metodiev K; Nenov D; Baran EY Transplant Proc; 1989 Feb; 21(1 Pt 2):1926-9. PubMed ID: 2652627 [No Abstract] [Full Text] [Related] [Next] [New Search]